(c) 2007 Elsevier B V All rights reserved “
“Objective: To

(c) 2007 Elsevier B.V. All rights reserved.”
“Objective: To explore the effect of demographics and single-nucleotide polymorphisms in cytochrome P450 (CYP) 2B6, 2A6, UDP-glucuronosyltransferase (UGT) 2B7, and the constitutive androstane receptor (CAR) genes on efavirenz pharmacokinetics in a Chilean cohort affected with human immunodeficiency virus.\n\nMethods: Timed plasma samples obtained throughout the dosing interval were analyzed for efavirenz concentrations with liquid chromatography/tandem mass spectrometry. DNA from whole-blood

samples was used for genetic analysis. Data were analyzed using a Mann-Whitney statistical test; furthermore, a Pearson or Spearman correlation was used. A multivariate analysis was then conducted Akt inhibitor using multiple linear regression by best subset analysis.\n\nResults: Overall 219 patients were included, 208 patients had measurable efavirenz levels and available genetic samples. The overall median (interquartile range) of efavirenz concentration was 2.6 (2.1-3.7) mcg/mL. In multivariate regression

analysis, CYP2B6 516G>T (P<0.0001) and CAR rs2307424 C>T (P = 0.002) were significantly Geneticin related to efavirenz plasma concentrations.\n\nConclusion: This novel association between CAR rs2307424 and efavirenz plasma concentrations now requires validation in other cohorts.”
“A 47-year-old healthy man developed acute fulminant coxsackie BI myocarditis with cardiogenic shock and extreme elevation of NT-pro-BNP (82585 pg/ml). He had a dramatic and rapid improvement within the following days after administration of corticoids on top of dobutamine and classic treatment.”
“Background: Torres Strait Islander population has a high prevalence of type 2 diabetes (T2DM).\n\nAims: To review pregnancy data of

women and their newborns living in the Torres Strait area.\n\nMethods: All medical charts of mothers and their neonates delivered in two one-year periods (1999 and 2005/2006) were reviewed. The initial screening test for diabetes Blebbistatin in pregnancy (DIP) was a random blood glucose level followed by an oral glucose challenge test in 1999 and from 2000 an oral glucose tolerance test.\n\nResults: Diabetes in pregnancy increased by 4.3-13.3% and T2DM by 0.8-4.6%. During the two periods, 258 and 196 mothers delivered respectively 84-92% by midwives/general practitioners at the local hospital and 7-16% by midwives/obstetricians at the regional hospital; in 2005/2006, 58% of women with DIP delivered at the regional hospital. Screening increased from 89.2 to 99.5%. DIP mothers were older and heavier with more hypertension and previous miscarriages. Parity decreased in the DIP mother during the two periods. Caesarean section was five times more common for DIP in 2005/2006 versus non-DIP, while in 1999, there was no difference. In 1999, the DIP infants were heavier, longer (P = 0.053) and had a larger head circumference not seen 2005/2006. There was more neonatal trauma, hypoglycaemia and IV dextrose in the DIP infants.

Comments are closed.